Liposomal phytohemagglutinin: In vivo T‐cell activator as a novel pan‐cancer immunotherapy
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Cellular and Molecular Medicine"
DOI: 10.1111/jcmm.16885
Abstract: Immunotherapy is an attractive approach for treating cancer. T‐cell engagers (TCEs) are a type of immunotherapy that are highly efficacious; however, they are challenged by weak T‐cell activation and short persistence. Therefore, alternative solutions to… read more here.
Keywords: liposomal phytohemagglutinin; cell; activate cells; immunotherapy ... See more keywords